A carregar...
SARS-CoV-2 spike therapeutic antibodies in the age of variants
Christos Kyratsous, Vice President of Research, Infectious Diseases, and Viral Vector Technologies at Regeneron Pharmaceuticals, and Alina Baum, Associate Director, Infectious Diseases Associate at Regeneron Pharmaceuticals, discuss the development of antibody therapeutics targeting the spike protei...
Na minha lista:
| Publicado no: | J Exp Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Rockefeller University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056769/ https://ncbi.nlm.nih.gov/pubmed/33871567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20210198 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|